Evaluating outcomes of middle meningeal artery embolization for chronic subdural hematoma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the real-world outcomes of chronic subdural hematoma (cSDH) treated with middle meningeal artery embolization (MMAE). It focuses on assessing clinical effectiveness, recurrence rates, and the safety profile of this minimally invasive treatment approach. The study involves a multi-center retrospective cohort design, analyzing data from adult patients who underwent MMAE. The goal is to determine whether this technique offers a favorable alternative to traditional surgical methods.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Consecutive adult patients (18 yrs. of age or older)
* Endovascular embolization of middle meningeal artery using any embolization material:

PVA particles; Onyx, N-butyl cyanoacrylate (nBCA) glue; dimethyl sulfoxide, microcoils, polyvinyl alcohol (PVA) with microcoils

Exclusion Criteria:

* Endovascular embolization of middle meningeal artery using any other embolization material

Where it's running

• Baptist Health South Florida, Inc.
  Coral Gables, Florida, United States Recruiting
• University of Miami
  Miami, Florida, United States Recruiting
• Orlando Regional Medical Center
  Orlando, Florida, United States Recruiting
• University of Chicago Medicine
  Chicago, Illinois, United States Recruiting
• Massachusetts General Hospital
  Boston, Massachusetts, United States Recruiting
• Beth Israel Deaconess Medical Center (BIDMC)/Harvard Medical School
  Boston, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: David Altschul, MD — Montefiore Medical Center
• Study coordinator: Muhammed Amir Essibayi, MD
• Email: muhammedamir.essibayi@einsteinmed.edu
• Phone: 347-908-1889

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Middle Meningeal Artery Embolisation to Prevent Recurrence of Chronic Subdural Hematoma

  This study tests whether embolising the middle meningeal artery around the time of hematoma evacuation can reduce recurrence in adults with chronic subdural hematoma.

  Recruiting at 6 sites University Hospital Hradec Kralove · České Budějovice and 5 other locations · NCT07751887

• What causes vulnerability in older adults with serious diseases and how it affects care decisions

  This study tests how often vulnerability factors appear in older adults with serious illnesses and how these factors influence treatment timing, survival, and quality of life.

  Recruiting Tampere University Hospital · Tampere · NCT07740239

• Coil embolization for unilateral vs bilateral chronic subdural hematomas

  This trial tests whether unilateral or bilateral coil-based embolization of the middle meningeal artery helps people with chronic subdural hematoma.

  Recruiting Lahey Clinic · Burlington, Massachusetts · NCT07715656

• Non-Thermal Plasma Used During Surgery to Help Prevent Recurrent Chronic Subdural Hematoma

  A randomized trial tests whether applying non-thermal plasma during standard surgery to drain a chronic subdural hematoma can reduce recurrence within 6 months.

  Recruiting National Institute of Nuclear Research - Mexico · Ocoyoacac, State of Mexico · NCT07656818

• Enhanced recovery pathway for burr-hole drainage in chronic subdural hematoma patients

  This project tests whether an enhanced recovery protocol for adults having burr-hole drainage for chronic subdural hematoma can reduce recurrence and complications compared with past patients.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07421453

• Matched microcatheter and guidewire use for middle meningeal artery embolization in chronic subdural hematoma

  This will test whether using a matched Aristotle 14 guidewire and Plato 17 microcatheter during middle meningeal artery embolization works better than surgeons' usual device choices for adults with chronic subdural hematoma.

  Recruiting Ohio State University · Columbus, Ohio · NCT07324551

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.